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Visual snapshots of intracellular kinase activity
can be acquired with exquisite temporal control
by using a light-activatable (caged) sensor,
thereby providing a means to interrogate enzy-
matic activity at any point during the cell-divi-
sion cycle. Robust protein kinase activity tran-
spires just prior to, but not immediately after,
nuclear envelope breakdown (NEB). Further-
more, kinase activity is required for the progres-
sion from prophase into metaphase. Finally, the
application of selective protein kinase C (PKC)
inhibitors, in combination with the caged sen-
sor, correlates the action of the PKC b isoform
with subsequent NEB.
INTRODUCTION
Cellular biochemistry is commonly assessed by using
lysates or cell-free model systems. However, in order to
directly correlate enzymatic activity with cellular behavior,
new tools must be developed to visualize the action of en-
zymes in cells, tissues, and, ultimately, living organisms.
Fluorescent microscopy provides the instrumental means
by which to observe intracellular biochemistry, but this
methodology is dependent on the design and construc-
tion of fluorescent sensors that can report changes in
the catalytic status of the target enzyme. However, live-
cell microscopy places unique demands on the sensor.
In particular, sensors that possess short-wavelength fluo-
rophores or exhibit modest enzyme-induced fluorescent
changes are insufficient for visualizing enzyme-catalyzed
reactions in living cells. The small volume of a typical
mammalian cell requires the fluorophore to be both bright
and highly responsive to its enzymatic target. Further-
more, the fluorophore must possess the proper photo-
physical properties (i.e., long-wavelength excitation and
emission) so that the endogenous fluorophores present
in the cell do not interfere with the readout. Finally, the
multitude of biochemical transformations transpiring in1254 Chemistry & Biology 14, 1254–1260, November 2007 ª20the cell at any given time requires that the sensor be rea-
sonably selective for its enzymatic target.
In addition to the concerns noted above, live-cell enzy-
mology offers a unique challenge that, in general, has no
counterpart in experiments that utilize pure enzymes or
cell lysates. One of the attractive features associated
with observing enzyme action in the natural intracellular
environment is that catalytic activity can be correlated
with cellular behavior. However, although the investigator
controls the start and stop points of enzyme-catalyzed
reactions in a typical cuvette-based experiment, the
biochemical apparatus of the cell controls the timing and
duration of intracellular enzymatic activity. The loss of
investigator control in live-cell enzymology has important
ramifications. For example, if the intracellular enzyme of
interest is constitutively active, then the time required for
loading the sensor into the cell could preclude the acqui-
sition of well-defined kinetics. In addition, since intracellu-
lar enzymatic activity can cycle on and off, the absence of
a fluorescent response in live-cell assays may not neces-
sarily be due to the absence of enzymatic activity, but it
could be a consequence of sensor consumption at an ear-
lier stage. Finally, loading any unnatural molecular entity
into a cell, particularly via microinjection or various cell-
permeablizing delivery systems, can stress the cell and
thus generate an artificial response. As a consequence,
it is common practice to allow the cell to recover after
the introduction of proteins, peptides, nucleic acids, etc.
For these reasons, aswell as others, it would prove advan-
tageous to devise reagents (inhibitors, sensors, sub-
strates, etc.) that can be delivered to the cell in an inert
form, but ones that are sensitive to subsequent activation
upon demand. In this regard, light-activatable species of-
fer the possibility of precise temporal control over sensor
activity even after the reagent has entered the cell [1].
Protein kinase activity is critical for the G2/M transition
[2–6], particularly at or around the time of nuclear envelope
breakdown (NEB). However, it is unknown if activity is
present prior to, during, or after NEB in living cells. We
recently described the PKC sensor 1 (Figure 1), an efficient
substrate for the conventional protein kinase C (PKC)
isoforms (a, b, and g) [7]. This peptide exhibits a readily ob-
servable fluorescent change upon phosphorylation. How-
ever, using sensor 1, we found that PKC is constitutively07 Elsevier Ltd All rights reserved
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PKC Activity at the Onset of MitosisFigure 1. Structures of PKC Sensors and Inhibitors
Compound 1 responds to PKC-catalyzed phosphorylation in a fluorescently sensitive fashion [7]. The nonphosphorylatable analog, 2, is converted to
the active sensor, 1, by photolysis [8]. Compound 3 is a selective PKC b inhibitor [11], whereas compound 4 serves as a selective PKC a inhibitor [12].active in interphase cells unless these cells have been se-
rum starved [7]. Consequently, the issue of sensor con-
sumption (i.e., complete phosphorylation of peptide 1)
prior to the key biological event (e.g., NEB) represents a
significant concern. By contrast, the corresponding caged
version, 2 (Figure 1), is not susceptible to phosphorylation
until it is photolyzed, which then furnishes the active sen-
sor, 1 [8]. In short, the caged derivative, 2, can be loaded
into cells and subsequently used to visualize kinase activ-
ity at any time point relative to NEB, without having to re-
sort to artificial constraints (e.g., serum starvation). We
have employed compound 2 to assess intracellular pro-
tein kinase activity at precise time intervals just prior to,
during, and immediately after NEB. In addition, in combi-
nation with known protein kinase inhibitors, we have iden-
tified the kinase responsible for both the phosphorylation
of the active sensor, 1, as well as mitotic progression from
prophase to metaphase.
RESULTS AND DISCUSSION
Peptide 1 as a Substrate for the PKC Isoforms
Present in PtK2 Cells
The PtK2 cell line was employed in this study because
these cells remain flat during mitosis and have large chro-
mosomes that allow for ready identification of the individ-
ual stages of mitosis. Western blot analysis revealed that
PtK2 cells express thea, b, i, m, q, and z isoforms (Figure 2).
We’ve previously shown that 1 is an outstanding substrate
for PKC a, b, and g [7]. The first two isoforms are present in
PtK2 cells, whereas PKC g is not (Figure 2). In addition,
we’ve found that peptide 1 serves as a weak substrate
for i, q, and z isoforms. Finally, the fluorescent sensor is
not phosphorylated by PKC m (Figure 3). These results
appear to be consistent with the previously described
substrate specificity of some of these isoforms [9]. The
conventional isoforms, a and b, are known to prefer sub-Chemistry & Biology 14, 1254–1260strates that possess positively charged residues (in partic-
ular Arg) at the +2 and +3 positions relative to the
phosphorylatable Ser moiety (i.e., -Ser-Xaa-Arg-Arg).
However,members of the novel and atypical PKC subfam-
ilies generally prefer hydrophobic residues at +2 and +3,
although they can tolerate positively charged amino acids
at these positions as well. In addition to the PKC family of
enzymes, a variety of other protein kinases have been
implicated asparticipants in the onset ofmitosis [10].How-
ever, theseenzymeseither fail to (Akt-1, AurB,Cdc-2, Plk1)
or only weakly (Nek2) phosphorylate peptide 1.
An Assessment of Protein Kinase Activity
at the Prophase-to-Metaphase Transition
The caged peptide, 2 (200 mM in needle; 2–20 mM final in-
tracellular concentration), and 70 kDa Texas red-dextran
(5 mM in needle) were coinjected into PtK2 cells. The Texas
red-dextran is excluded from the intact nucleus and thus
provides an easily visualized readout of NEB, which tran-
spires over a period of 2 min (Figure 4A; Movies S1 and
S2, see the Supplemental Data available with this article
online). In general, photolysis (1 s) of individual cells during
prophase generates a time-dependent increase in fluores-
cence (Figure 4A), followed by NEB. Interestingly, the few
cells (3 out of 18) that failed to display a fluorescence
change in prophase also failed to undergo subsequent
NEB, suggesting that the former is required for the latter
to transpire. As a control, we found that microinjection
with buffer alone results in a fraction of cells that do not
progress to NEB (8 out of 30). Apparently, the stress of mi-
croinjection can have deleterious consequences in a small
fraction of cells in terms of mitotic progression. Neverthe-
less, the majority of cells (>80%) microinjected with sen-
sor share several key enzymological and behavioral prop-
erties: (a) a fluorescent enhancement observed until NEB
in all cells that exhibit subsequent NEB, (b) a rate of fluo-
rescence change that levels off as the nuclear envelope, November 2007 ª2007 Elsevier Ltd All rights reserved 1255
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PKC Activity at the Onset of MitosisFigure 2. Western Blots of PKC Isoforms
Present in Ptk2 Cellscollapses, and (c) generally unchanged fluorescence after
NEB. These results are consistent with the notion that PKC
is active prior to NEB but is rendered inactive after nuclear
collapse. However, another interpretation is that all sensor
molecules have been phosphorylated by the time the cell
reaches the NEB signpost. Consequently, the experi-
ments outlined in Figure 4A were repeated, but the caged
peptide, 2, was photoactivated immediately after NEB, as
signified by the appearance of Texas red-dextran within
the former nuclear region. Under these conditions, there
was no significant change in reporter fluorescence inten-
sity (14 out of 16 cells exhibited no fluorescence change,
and 2 out of 16 cells displayed a <15% fluorescence
change) for up to 9 min after NEB (Figure 4B). These re-
sults suggest that kinase activity is biochemically
switched off after the collapse of the nuclear envelope.
Finally, we also established that the post-NEB phosphor-
ylation state of peptide 1 is not altered by intracellular
phosphatases because we failed to observe any change
in fluorescence (8 of 10 cells displayed no fluorescence
change, and 2 out of 10 exhibited a <15% fluorescence
change) in the presence of the general phosphatase inhib-
itor okadaic acid (Figure 4C).
Protein Kinase Inhibitors Establish PKC b
as the Sensor Kinase
Although the sensor experiments expose a clean demar-
cation in kinase activity prior to and immediately after
Figure 3. PKC Isoform-Catalyzed Phosphorylation of Peptide
1 as a Function of Time1256 Chemistry & Biology 14, 1254–1260, November 2007 ª20NEB, they do not reveal which kinase is responsible for
sensor phosphorylation, nor do they establish a kinase-
dependent cause and effect with nuclear collapse. As
noted above, Nek2 as well as the a, b, i, m, q, and z iso-
forms of PKC are capable of catalyzing the phosphoryla-
tion of peptide 1. Inhibitors that selectively target each of
these individual enzymes would be helpful in assessing
which of these kinases is responsible for sensor phos-
phorylation. In addition, these inhibitors could prove
particularly useful in correlating the activity of a specific
kinase with the subsequent NEB signpost.
Compound 3 (Figure 1) has been reported to be a selec-
tive PKC b inhibitor compared to the a and 3 isoforms [11].
However, its selectivity compared to other PKC isoforms
has not been explicitly addressed. Consequently, in addi-
tion to PKC a and b, we examined the inhibitory potency of
this derivative against the other isoforms present in PtK2
cells, namely, i, m, q, and z. Compound 3 exhibits an
IC50 of 11 ± 1 nM for the bII isoform, which is consistent
with the previously reported value of 5 nM [11]. By con-
trast, the IC50 values for the other PKC isoforms are signif-
icantly larger. The IC50 for PKC a is 1.3 ± 0.1 mM, and there
is no observable inhibition for the i, m, q, or z isoforms or
the Nek2 protein kinase when 3 is present at 50 mM. Con-
sequently, compound 3 serves as a highly selective inhib-
itor for the b isoform. With this in mind, we examined the
effect of compound 3 (12 mM in the cell media) on mitotic
progression. We found that 65%of PtK2 cells (20 out of 31
cells) did not proceed from prophase into metaphase in
the presence of 3. These results indicate that passage
through NEB is not dependent upon Nek2, nor on the i,
m, q, or z PKC isoforms, because compound 3 does not
inhibit these enzymes at 12 mM. However, the 12 mM con-
centration of the indolylmaleimide, 3, required to establish
anNEBblock in themajority of the cells is10-fold greater
than the IC50 value for PKC a and is significantly greater
than that for PKC b obtained under in vitro conditions.
Consequently, although use of compound 3 rules out
Nek2 and the i, m, q, or z PKC isoforms as effectors of pep-
tide 1 phosphorylation and NEB, it does not allow us to
conclusively distinguish between the PKC a or b isoforms
as the sensor 1 kinases.
The PKC a inhibitor, 4 (Figure 1, Ki = 800 pM), displays
a 385-fold selectivity compared to PKC b and an even
greater selectivity compared to the other PKC isoforms07 Elsevier Ltd All rights reserved
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PKC Activity at the Onset of MitosisFigure 4. Protein Kinase Activity prior to
and after Nuclear Envelope Breakdown
(A) Time course of the phosphorylation of pep-
tide 1 prior to NEB. The nonphosphorylatable
analog, 2, and 70 kD Texas red-dextran were
simultaneously microinjected into PtK2 cells.
Cells were illuminated (1 s) during prophase
(i.e., prior to NEB) to convert the inert sensor,
2, to its active form, 1, and the fluorescence
change as a function of time was recorded
with respect to NEB. Each progress curve is
derived from a single cell, and a total of 18 cells
were examined (6 of the progress curves are
shown here).
(B) Time course of the phosphorylation of pep-
tide 1 after NEB. PtK2 cells were treated as in
Figure 2A, except that photolysis was per-
formed after NEB. The progress curve repre-
sents the average fluorescence change of 16
cells (each data point represents the mean ±
SD).
(C) Fluorescence change after NEB in the pres-
ence of okadaic acid (1.5 mM).[12]. The caged sensor, 2, and Texas red-dextran were co-
injected along with two different concentrations of the
PKC a-selective inhibitor, 4: 2mM (intracellular concentra-
tion: 20–200 mM) and 1 mM (intracellular concentration:
10–100 nM). The cells were photolyzed to convert the
caged sensor, 2, into the active species, 1. Under the first
set of conditions (i.e., 2 mM inhibitor 4), both PKC a and
b should be inhibited, whereas under the latter conditions
(i.e., 1 mM inhibitor 4), only the activity of PKC a should be
compromised. Cells microinjected with 2 mM inhibitor 4
fail to exhibit PKC activity and do not progress through
NEB (n = 10 cells). By contrast, cells injected with a
1 mM stock solution of the PKC a-selective inhibitor, 4,
exhibit both PKC activity and NEB (12 out of 15 cells). In
short, compound 3 blocks sensor 1 phosphorylation as
well as NEB at a concentration that is only consistent
with catalysis by either PKC a or b. Subsequent studies
with compound 4 eliminated PKC a as the kinase sensor,
thereby suggesting that PKC b is the intracellular peptide 1
kinase required for NEB. The results are consistent with
those reported by Fields and coworkers, who first identi-
fied PKC b as a mitotic lamin kinase [4–6].
Ptk2 cells express both the type I and type II isoforms of
PKC b. These otherwise identical enzymes differ only in
their C-terminal 50/52 amino acids [13]. Unfortunately,
there are no reported inhibitors or substrates that discrim-
inate between these two closely related enzymes. There
have been several reports describing the differential trans-
location of bI and bII in response to environmental stimuli
[14–16]. For example, Becker and Hannun have shown
that both isoforms, when overexpressed in HeLa cells,
are diffusely distributed throughout the cytoplasm and
excluded from the nucleus [16]. Upon phorbol ester stim-
ulation, however, bI migrates exclusively to the plasma
membrane, whereas bII is positioned at both the plasmaChemistry & Biology 14, 1254–126membrane as well as a juxtanuclear location. To the
best of our knowledge, the distribution of the two PKC
b isoforms has not been examined as a function of cell cy-
cle. Immunocytochemistry revealed a marked difference
in the localization of bI and bII in nonmitotic cells. ßI is pre-
dominantly associated with the nucleus, both during inter-
phase and in prophase (Figure 5). Furthermore, since the
isoform is excluded from the nucleolus, this implies that
bI is present in the nucleus itself and is not merely associ-
atedwith the nuclear membrane (the latter would generate
a uniform distribution about the nucleus). By contrast, bII
is distributed throughout the cytoplasm during interphase
(Figure 5). Upon entry into prophase, the subcellular distri-
bution of bI remains unchanged, namely, this isoform
Figure 5. Localization of PKC b Isoforms in Prophase
Cells stained with PKC bI (upper panel) or PKC bII (lower panel) anti-
bodies and DAPI. The arrows highlight cells in prophase. All other cells
are in interphase. The scale bar is 50 mm.0, November 2007 ª2007 Elsevier Ltd All rights reserved 1257
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PKC Activity at the Onset of Mitosisretains its association with the nucleus. By contrast, bII
undergoes a partial subcellular redistribution as it accu-
mulates at or near the nuclear boundary. In short, the sub-
cellular distribution of both isoforms is consistent with
a role in promoting nuclear collapse (i.e., via lamin phos-
phorylation). However, it is tempting to speculate that
the cycle-dependent accumulation of bII at the periphery
of the nucleus may be significant, particularly with respect
to subsequent NEB.
Previous studies primarily employed cell-free systems
to implicate PKC b as a lamin kinase activated prior to
NEB [4]. In addition, these studies employed cell lysates,
which were obtained from a large population of chemically
induced synchronized cells. Unfortunately, cells released
from aphidicolin or nocodazole blockades rarely progress
through the division cycle as a uniform population. Fur-
thermore, some cell lines, such as PtK2 cells, cannot be
synchronized. The latter is especially unfortunate given
the utility of this particular cell line as the exemplary model
system by which to study mitosis. Perhaps most impor-
tantly, however, lysates from large cell populations are
simply not ideal for examining short, yet critical time
points, which encompass key cellular events. By contrast,
the light-activatable sensor, 2, provides a temporally pre-
cise method by which to interrogate protein kinase activity
in an investigator-controlled fashion. In particular, we
found that protein kinase activity is vigorous just prior to
NEB, but is abruptly switched off after NEB. Furthermore,
in combination with selective protein kinase inhibitors, we
identified PKC b as the protein kinase that phosphorylates
sensor 1 prior to nuclear envelope collapse.
SIGNIFICANCE
Live-cell enzymology represents unique challenges
that generally do not need to be confronted in studies
with pure enzymes or cell lysates. In particular, the
cell, and not the investigator, controls the timing of
enzymatic activity. Caged analogs of sensors, inhibi-
tors, substrates, and other biologically active species
offer a means by which to retain control over reagent
activity even after it has entered the cell. In short,
light-activatable species allow the investigator to
choose, with high temporal precision, when to assess,
alter, or otherwise control intracellular enzymology.
We employed this strategy to evaluate protein kinase
C (PKC) activity in the minutes immediately prior to,
during, and after nuclear envelope breakdown (NEB),
the mitotic landmark that serves as the transition
from prophase to metaphase. Activation of the sensor
in an investigator-controlled temporally precise fash-
ion revealed that intracellular protein kinase activity
is vigorous just prior to NEB, but is abruptly switched
off after nuclear collapse. An array of PKC isoform-
selective inhibitors was employed to demonstrate
that PKC b serves as the mitotic kinase that catalyzes
the phosphorylation of the sensor and drives the tran-
sition from prophase to metaphase.1258 Chemistry & Biology 14, 1254–1260, November 2007 ª20EXPERIMENTAL PROCEDURES
Spectrofluorometric Assays
All spectrofluorometric measurements were carried out on a Photon
Technology QM-1 Instrument at 30C. The photomultiplier tube setting
was held constant at 1000 V during all measurements. The assay vol-
ume and pHwere maintained at 200 ml and 7.5, respectively. The reac-
tion was initiated by the addition of enzyme (10 ml) into the sensor
(compound 1) assay buffer solution (190 ml), and the time-dependent
change in fluorescence intensity (lex = 520 nm; lem = 560 nm) was con-
tinuously monitored. For a direct comparison of relative activities of
various PKC isoforms and other protein kinases toward sensor 1, all
measurements were carried out under optimum experimental condi-
tions for the enzymes. For (A) PKC a, b, and g: 62.5 mM HEPES (pH
7.5), MgCl2 (3 mM), CaCl2 (0.3 mM), EGTA (0.1 mM), ATP (1 mM),
DTT (1 mM), PS (0.1 mg/ml), DAG (0.1 mg/ml), enzyme (50 nM), and
compound 1 (100 mM); (B) PKC z and i: 62.5 mM HEPES (pH 7.5),
MgCl2 (10 mM), EGTA (0.5 mM), PS (0.04 mg/ml), ATP (1 mM), DTT
(1 mM), enzyme (50 nM), and compound 1 (100 mM); (C) PKC m, 3, d,
q, and h: 62.5 mM HEPES (pH 7.5), MgCl2 (10 mM), EGTA (0.5 mM),
PS (0.04 mg/ml), DAG (0.01 mg/ml), ATP (1 mM), DTT (1 mM), enzyme
(50 nM), and compound 1 (100 mM); (D) Nek2: 50 mM Tris-HCl buffer
(pH 7.5), MgCl2 (10 mM), DTT (1 mM), ATP (1 mM), enzyme (50 nM),
and compound 1 (100 mM); (E) Cdc2: 50 mM Tris-HCl buffer (pH 7.5),
MgCl2 (10 mM), DTT (2 mM), EGTA (1 mM), Brij 35 (0.01%), enzyme
(‘‘2 units’’), and compound 1 (100 mM); (F) Akt: 20 mM Tris-HCl buffer
(pH 7.5), MgCl2 (10 mM), DTT (5 mM), enzyme (50 nM), and compound
1 (100 mM); (G) Plk1: 50 mM HEPES buffer (pH 7.5), MgCl2 (10 mM),
DTT (2.5 mM), Triton X-100 (0.01%), enzyme (50 nM), and compound
1 (100 mM); (H) Aurora kinase B: 50 mM Tris-HCl buffer (pH 7.5), MgCl2
(10 mM), enzyme (50 nM), and compound 1 (100 mM).
IC50 Determination of PKC b Inhibitor 3 against PKC Isoforms
All inhibition studies were performed by using the [g-33P]ATP radio-
active method in a 96-well plate format at 30C. Optimal conditions
(including specific peptide substrates) were chosen for the classical,
novel, and atypical PKC isoforms as follows: (A) PKC a and bII: an as-
say volume of 50 ml/well was used. Thus, the assay involving 100 mM
ATP was performed as follows. A 20 ml aliquot of inhibitor 3, appropri-
ately diluted in 1:4 DMSO:H2O, was added (final concentration = 3310,
1655, 827.5, 413.75, 206.87, 103.4, 51.7, 25.6, 12.9, and 0 nM) to 20 ml
assay buffer to give a final concentration of 62.5 mM HEPES (pH 7.5),
MgCl2 (10 mM), EGTA (0.5 mM), CaCl2 (0.8 mM), DAG (17.6 mg/ml), PS
(100 mg/ml), peptide substrate Ac-Ser-Phe-Arg-Arg-Arg-Arg-NH2
(75 mM), and cold ATP (100 mM or 1 mM), supplemented with
1.5 mCi/well [g-33P]ATP for radioactive detection. The reaction was ini-
tiated with the addition of 10 ml enzyme buffer containing 20 mM Tris
(pH 7.5), PKC (final concentration = 0.1 ng/ml), BSA (final concentra-
tion = 0.15 mg/ml), EDTA (final concentration = 0.2 mM), and DTT (final
concentration = 0.2 mM). The reaction was allowed to progress for
15 min at 30C and was quenched subsequently with 6% phosphoric
acid (100 ml). An aliquot of 75 ml quenched reaction mixture was trans-
ferred to P81 cellulose phosphate paper unifilter plates, and the solu-
tion was allowed to stand for 12 min. The solution was then filtered off,
and the membrane was washed with 0.1% phosphoric acid (43), fol-
lowed by water. The scintillation fluids (100 ml) were then added, and
counting was performed on a 1420 MicroBeta counter (Perkin Elmer).
The rate of reaction was assessed by the incorporation of 33P into the
peptide substrate. (B) PKC m: performed as described above, except
that CaCl2 was not added and the peptide substrate Ala-Ala-Leu-
Val-Arg-Gln-Met-Ser-Val-Ala-Phe-Phe-Phe-Lys-OH (EMD Biosci-
ences) was employed at a final concentration of 60 mM. (C) PKC i
and z: performed as described above, except that CaCl2 and DAG
were not added and the peptide substrate Ac-Pro-Arg-Lys-Arg-
Gln-Gly-Ser-Val-Arg-Arg-Arg-Val-NH2 was employed at a final con-
centration of 75 mM. SigmaPlot, Enzyme Kinetics 1.1, was used for
data analyses.07 Elsevier Ltd All rights reserved
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Cells were lysed (Laemmli sample buffer containing chymostatin, leu-
peptin, and pepstatin), and proteins were separated on a 4%–20%
Tris-HCl SDS-PAGE gel and subsequently transferred overnight onto
a Immuno-Blot PVDF membrane at 4C. The membrane was incu-
bated with 5% nonfat dry milk solution in Tris Buffer Saline with Tween
(0.05%) for 1 hr, and the membrane was incubated with primary anti-
bodies in 5% nonfat dry milk solution in TBS-T for 3 hr at room temper-
ature. The following dilutions of primary antibodies were used, as rec-
ommended by themanufacturers: PKC a (1:500); b1 (1:500); bII (1:500);
q (1:200); m (1:1000); z (1:1000); i (1:200); g (1:1000); d (1:500); 3
(1:1000); h (1:1000); l (1:1000). After incubation with primary antibody,
the membrane was washed with TBS-T for 15 min (23) and treated for
1 hr at room temperature with secondary antibodies (1:2000 dilution)
conjugated to horseradish peroxidase (HRP). Themembrane was sub-
sequently washed for 15 min (23) with TBS-T and treated with HRP
substrate (Pierce SupersignalWest Pico Chemiluminescent Substrate)
for 1 min, and the chemiluminescent signal was detected on film.
Live-Cell Enzymology
PtK2 cells were cultured at 37C for 2–3 days (70%–80% confluence)
on 50 mm MatTek glass-bottom dishes (MatTek Corp, Ashland, MA)
containing photo-etched gridded coverslips (thickness 0.19–0.22 mm)
in Dulbeco’s MEM with nonessential amino acids and 10% FBS in
a humidified atmosphere containing 5% CO2. Prior to microinjection,
the dishes were washed three times with PBS, and then 4 ml L-15
medium (without phenol red) supplementedwith 10%FBSwas added.
The caged sensor, 2 (synthesized and characterized as previously
described [8]), was dissolved in PBS at a concentration of 200 mM
and prefiltered through a 0.22 mm centrifuge filter. Cells were microin-
jected with the 200 mM caged sensor and 1 mM 70K dextran tagged
with Texas red (Molecular Probes, Eugene, OR) by using a commercial
microinjection system (Transjectors 5246, Eppendorf, Westbury, NY)
at an estimated final concentration of 2–20 mM for the caged peptide
and 10–100 nM Texas red-dextran. The estimate for dilution via micro-
injection was obtained from the equation for volume (V) flow through
a capillary tube (V/t = ppr4/8lh), where p is the difference in pressure
at the ends of the tube (290 hPa), r is the radius (0.05 mm), l is the length
(10 mm) of the tube, h is the viscosity of the injected solution (0.69 3
102 g/cm s), and t is the total injection time (0.3 s). The average vol-
ume of a fibroblast is taken as 2 pl [17]. Cells were exposed to UV illu-
mination from a 100WHg-Arc lamp (by using a set of 2 KG5 heat filters
in the light path and a narrow band pass DAPI filter of 355 ± 10 nm)
through a PlanApo 403 N.A. 0.75 objective for 1 s to activate the sen-
sor (i.e., only cells in the immediatemicroscopic field were illuminated).
Immediately after UV treatment, time-lapse images were collected
with 23 2 binning by using a Cooke SensicamQE cooled CCD camera
(driven by IPlab software) mounted on an Olympus 1X70 inverted
microscope (Melville, NY) with a PlanApo 403, 0.75 N.A. objective in
conjunction with a 1.53 ‘‘booster’’ slider, and a FITC filter set with an
excitation wavelength of 460–500 nm and an emission wavelength of
510–560 nm. A long working distance condenser (N.A. 0.55) was
used. Images were collected every minute for 9–30 min (1000 ms
exposure time). The digitized images were analyzed by using ImageJ
to measure the mean intensity of the whole cell. Images and fluores-
cence intensity measurements were also obtained from control cells
that were injected with the same caged sensor in the presence of
200 mM staorosporine to make photobleaching adjustments. For
experiments involving the PKCb inhibitor, 3, or the phosphatase inhib-
itor okadaic acid, cells were incubated with the relevant inhibitor for at
least 1 hr prior to microinjection.
Immunofluorescence
To examine the distribution of PKC bI and II isoforms throughout the
cell cycle, PtK2 cells growing on glass coverslips were fixed in freshly
prepared 3.7% formaldehyde in PBS for 15min, permeabilized for 20 s
with20C acetone, immediately rehydrated in PBS containing 0.02%
azide, and blocked in PBS containing 1%bovine serum albumin (BSA).Chemistry & Biology 14, 1254–1260Cells were then incubated with primary PKC bI (C-16) sc-209 or PKC
bII (C-18) sc-210 rabbit polyclonal antibodies (Santa Cruz Biotechnol-
ogy) at a dilution of 1:100 in PBS containing 1% BSA for 1 hr at room
temperature. After washing with 1% BSA in PBS, cells were incubated
with a Cy3-conjugated donkey anti-rabbit antibody (Jackson Immu-
noResearch Lab) at a dilution of 1:500 in 1% BSA in PBS for 40 min
at room temperature and rinsed again. Coverslips were incubated
with DAPI (Sigma) at 0.1 mg/ml in 1% BSA in PBS for 10 min before
mounting in Pro-Long Antifade (Molecular Probes). Immunofluores-
cence images were acquired by using IPLab Spectrum software (Sca-
nalytics, Inc.) and a CoolSNAPHQ interline 12-bit, cooled CCD camera
(Roper Scientific) mounted on an Olympus IX70 microscope with
a PlanApo 603, 1.4 N.A. objective (Olympus) and HiQ bandpass filters
(Chroma Technology Corp.). Images were processed by using Photo-
shop (Adobe Systems).
Supplemental Data
Supplemental Data include two movies and are available online at
http://www.chembiol.com/cgi/content/full/14/11/1254/DC1/.
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